Stonegate Investment Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stonegate Investment Group's AMGN Position: Q3 2025 in Review
Stonegate Investment Group increased its Amgen (AMGN) stake by 0.13% in Q3 2025, buying an estimated $4.35K and bringing the position to 11,472 shares worth $3.24M. The position accounts for 0.08% of the portfolio, ranked #105.
Stonegate Investment Group first reported a position in AMGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $83.3M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Stonegate Investment Group held 11,472 shares of Amgen worth $3.24M as of Q3 2025.
- Stonegate Investment Group bought 15 Amgen shares in Q3 2025, an estimated $4.35K.
- Amgen made up 0.08% of Stonegate Investment Group's portfolio in Q3 2025, its #105 holding.
- Stonegate Investment Group first reported a position in Amgen in Q2 2022 and has held it in 14 quarters since.
- Stonegate Investment Group's Amgen position peaked at $83.3M in Q3 2024.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.